Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

More Than Stress Hyperglycemia: Acute Pancreatitis as a Prelude to Diabetes.

Diabetes care·2026
Same author

Melatonin improves postprandial hypoglycemia: an unusual presentation of insulinoma.

JCEM case reports·2026
Same author

Pregnancies Affected by Diabetes in Teenagers and Emerging Adults: A Population-Based Study.

Metabolic syndrome and related disorders·2026
Same author

Integrated glucagon model for estimation of α-cell responsivity to glucose and amino acids during graded glucose infusion.

American journal of physiology. Endocrinology and metabolism·2026
Same author

Hepatic steatosis in humans is associated with preserved glucagon action on amino acid metabolism.

The Journal of clinical investigation·2025
Same author

Modeling the effect of glucagon on endogenous glucose production in healthy individuals under meal-like conditions.

American journal of physiology. Regulatory, integrative and comparative physiology·2025
Same journal

Contents.

Medicine (Abingdon, England : UK ed.)·2022
Same journal

Cardiopulmonary resuscitation.

Medicine (Abingdon, England : UK ed.)·2022
Same journal

Non-infective complications for people living with HIV.

Medicine (Abingdon, England : UK ed.)·2022
Same journal

The HIV epidemic: global and United Kingdom trends.

Medicine (Abingdon, England : UK ed.)·2022
Same journal

Influenza: epidemiology and hospital management.

Medicine (Abingdon, England : UK ed.)·2021
Same journal

Fever in the returning traveller.

Medicine (Abingdon, England : UK ed.)·2021
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

What is type 2 diabetes?

Galina Smushkin1, Adrian Vella

  • 1Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, MN, USA.

Medicine (Abingdon, England : UK Ed.)
|December 15, 2010
PubMed
Summary
This summary is machine-generated.

Type 2 diabetes, a metabolic disorder causing chronic hyperglycemia, involves complex mechanisms beyond high blood sugar. Understanding these underlying processes is crucial for effective management and treatment of this widespread condition.

Related Experiment Videos

Last Updated: Jun 6, 2026

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Diabetes Research

Background:

  • Type 2 diabetes is a prevalent metabolic disorder marked by chronic hyperglycemia.
  • It significantly reduces life expectancy due to increased risks of cardiovascular disease, neuropathy, renal disease, and other complications.
  • Current predictors include elevated fasting glucose, impaired glucose tolerance, obesity, and insulin resistance.

Purpose of the Study:

  • To explore the complex mechanisms underlying the progression to overt type 2 diabetes.
  • To highlight that hyperglycemia is only one aspect of this heterogeneous disease.
  • To emphasize the need to understand underlying mechanisms beyond just high blood glucose levels.

Main Methods:

  • Review of existing literature on type 2 diabetes pathogenesis.
  • Analysis of factors contributing to disease progression from prediabetes to overt diabetes.
  • Discussion of the diagnostic definition of type 2 diabetes and its implications.

Main Results:

  • The mechanisms driving progression from impaired glucose tolerance to type 2 diabetes are not fully elucidated.
  • Type 2 diabetes is often defined negatively, focusing on hyperglycemia without considering all underlying causes.
  • This diagnostic approach leads to disease heterogeneity and overlooks crucial pathogenic pathways.

Conclusions:

  • Hyperglycemia is a key feature but not the sole abnormality in type 2 diabetes.
  • A deeper understanding of the diverse underlying mechanisms is essential for comprehensive disease management.
  • Rethinking the definition and diagnostic criteria may improve understanding and treatment of type 2 diabetes.